Author:
Altibi Ahmed M.,Pallavi Bhargava,Liaqat Hassan,Slota Alexander A.,Sheth Radhika,Al Jebbawi Lama,George Matthew E.,LeDuc Allison,Abdallah Enas,Russell Luke R.,Jain Saniya,Shirvanian Nariné,Masri Ahmad,Kak Vivek
Abstract
AbstractPrisons in the United States have become a hotbed for spreading COVID-19 among incarcerated individuals. COVID-19 cases among prisoners are on the rise, with more than 143,000 confirmed cases to date. However, there is paucity of data addressing clinical outcomes and mortality in prisoners hospitalized with COVID-19. An observational study of all patients hospitalized with COVID-19 between March 10 and May 10, 2020 at two Henry Ford Health System hospitals in Michigan. Clinical outcomes were compared amongst hospitalized prisoners and non-prisoner patients. The primary outcomes were intubation rates, in-hospital mortality, and 30-day mortality. Multivariable logistic regression and Cox-regression models were used to investigate primary outcomes. Of the 706 hospitalized COVID-19 patients (mean age 66.7 ± 16.1 years, 57% males, and 44% black), 108 were prisoners and 598 were non-prisoners. Compared to non-prisoners, prisoners were more likely to present with fever, tachypnea, hypoxemia, and markedly elevated inflammatory markers. Prisoners were more commonly admitted to the intensive care unit (ICU) (26.9% vs. 18.7%), required vasopressors (24.1% vs. 9.9%), and intubated (25.0% vs. 15.2%). Prisoners had higher unadjusted inpatient mortality (29.6% vs. 20.1%) and 30-day mortality (34.3% vs. 24.6%). In the adjusted models, prisoner status was associated with higher in-hospital death (odds ratio, 2.32; 95% confidence interval (CI), 1.33 to 4.05) and 30-day mortality (hazard ratio, 2.00; 95% CI, 1.33 to 3.00). In this cohort of hospitalized COVID-19 patients, prisoner status was associated with more severe clinical presentation, higher rates of ICU admissions, vasopressors requirement, intubation, in-hospital mortality, and 30-day mortality.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Akiyama, M. J., Spaulding, A. C. & Rich, J. D. Flattening the curve for incarcerated populations—Covid-19 in jails and prisons. N. Engl. J. Med. 382(22), 2075–2077 (2020).
2. Hawks, L., Woolhandler, S. & McCormick, D. COVID-19 in prisons and jails in the United States. JAMA Intern. Med. 180(8), 1041–1042 (2020).
3. A State-by-State Look at Coronavirus in Prisons | The Marshall Project [Internet]. [cited 2020 Jun 22]. Available from: https://www.themarshallproject.org/2020/05/01/a-state-by-state-look-at-coronavirus-in-prisons#.
4. Saloner, B., Parish, K., Ward, J. A., DiLaura, G. & Dolovich, S. COVID-19 Cases and Deaths in Federal and State Prisons. JAMA [Internet]. 2020 July 8 [cited 2020 Jul 9]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32639537.
5. Tomes, N. “Destroyer and teacher”: managing the masses during the 1918–1919 influenza pandemic. Public Health Rep. 125(Suppl 3), 48–62 (2010).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献